← 產業報告目錄
Flow Cytometry in Oncology and Immunology Market Size, Share & Trends Analysis Report by Offering (Products and services), by Technology, by Type(Immunology, Oncology, Solid Tumor), by Application, by End-User, by Region, And Segment Forecasts, 2025-2034
出版商 InsightAce Analytic產業別 Healthcare & Life Sciences出版日期 2026-03-27頁數 185報告編號 INSIGHTACE-47afbbfcf5
授權報價
| Single User PDF | $4,500 USD |
| Global Site License PDF | $9,500 USD |
報告摘要
With a 2024 valuation of USD 2.2 Bn, the global Flow Cytometry in Oncology and Immunology Market is expected to advance to USD 6.7 Bn by 2034, demonstrating a CAGR of 11.7% during the 2025–2034 forecast window.
Flow Cytometry in Oncology and Immunology covers key industry insights & findings from the report:
New technology flow cytometry devices and consumables are hitting the market at a rapid pace, and the growing incidence of cancer and hiv/aids are al. Rapid advancements and evolving end-user preferences are reshaping how healthcare entities approach this space.
Several factors contribute to this trajectory, including heightened call for next-generation products, expanding applications across diverse end-use sectors, and supportive government initiatives.
The market landscape is structured across several key segments—spanning type, application, distribution channel, and region—each contributing uniquely to overall market expansion.
Geographically, North America maintains a leading position owing to advanced infrastructure, high R&D expenditure, and a well-established regulatory environment. Meanwhile, Asia-Pacific is emerging as the fastest-growing region, propelled by rapid industrialization and expanding end-user bases.
Competition in this space is characterized by active product development, strategic collaborations, and geographic expansion among both global leaders and specialized niche players.
This comprehensive research study delivers granular insights into market sizing, trend analysis, competitive benchmarking, and forward-looking projections to support strategic decision-making for industry participants and investors.
目錄 Table of Contents
Chapter 1. Methodology and Scope
1.1. Research Methodology
1.2. Research Scope & Assumptions
Chapter 2. Executive Summary
Chapter 3. Global Flow Cytometry in Oncology and Immunology Market Snapshot
Chapter 4. Global Flow Cytometry in Oncology and Immunology Market Variables, Trends & Scope
4.1. Market Segmentation & Scope
4.2. Drivers
4.3. Challenges
4.4. Trends
4.5. Investment and Funding Analysis
4.6. Industry Analysis – Porter's Five Forces Analysis
4.7. Competitive Landscape & Market Share Analysis
4.8. Impact of Covid-19 Analysis
Chapter 5. Market Segmentation 1: by Offering Estimates & Trend Analysis
5.1. by Offering & Market Share, 2024 & 2034
5.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2021 to 2034 for the following by Offering:
5.2.1. Products
5.2.1.1. Instruments
5.2.1.2. Reagents and Consumables
5.2.1.3. Software
5.2.2. Services
Chapter 6. Market Segmentation 2: by Technology Estimates & Trend Analysis
6.1. by Technology & Market Share, 2024 & 2034
6.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2021 to 2034 for the following by Technology:
6.2.1. Cell-Based Flow Cytometry
6.2.2. Bead-Based Flow Cytometry
Chapter 7. Market Segmentation 3: by Type Estimates & Trend Analysis
7.1. by Type & Market Share, 2024 & 2034
7.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2021 to 2034 for the following by Type:
7.2.1. Immunology
7.2.2. Oncology
7.2.2.1. Hematological Malignancies
7.2.2.1.1. Hematological Malignancies (by Type)
7.2.2.1.1.1. Lymphoma
7.2.2.1.1.2. Leukemia
7.2.2.1.1.3. Myeloma
7.2.2.1.1.4. Other Hematological Malignancies
7.2.2.1.2. Hematological Malignancies (by Technology)
7.2.2.2. Solid Tumor
7.2.2.3. Solid Tumor (by Type)
7.2.2.3.1. Breast Cancer
7.2.2.3.2. Prostate Cancer
7.2.2.3.3. Colorectal Cancer
7.2.2.3.4. Lung Cancer
7.2.2.3.5. Liver Cancer
7.2.2.3.6. Ovarian Cancer
7.2.2.3.7. Other Solid Tumors
7.2.2.4. Solid Tumor (by Technology)
Chapter 8. Market Segmentation 4: by Application Estimates & Trend Analysis
8.1. by Application & Market Share, 2024 & 2034
8.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2021 to 2034 for the following by Application:
8.2.1. Translational Research
8.2.2. Clinical Research
8.2.2.1. Screening and Diagnostics
8.2.2.2. Monitoring and Treatment
Chapter 9. Market Segmentation 5: by End User Estimates & Trend Analysis
9.1. by End User & Market Share, 2024 & 2034
9.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2021 to 2034 for the following by End User:
9.2.1. Hospitals, Diagnostic Laboratories, and Reference Laboratories
9.2.2. Pharmaceutical and Biotechnology Companies
9.2.3. Academic Research Institutes
9.2.4. Contract Research Organizations
9.2.5. Others
Chapter 10. Flow Cytometry in Oncology and Immunology Market Segmentation 8: Regional Estimates & Trend Analysis
10.1. North America
10.1.1. North America Flow Cytometry in Oncology and Immunology Market Revenue (US$ Million) Estimates and Forecasts by Offering, 2021-2034
10.1.2. North America Flow Cytometry in Oncology and Immunology Market Revenue (US$ Million) Estimates and Forecasts by Technology, 2021-2034
10.1.3. North America Flow Cytometry in Oncology and Immunology Market revenue (US$ Million) by Type, 2021-2034
10.1.4. North America Flow Cytometry in Oncology and Immunology Market revenue (US$ Million) by Application, 2021-2034
10.1.5. North America Flow Cytometry in Oncology and Immunology Market revenue (US$ Million) by End User, 2021-2034
10.1.6. North America Flow Cytometry in Oncology and Immunology Market Revenue (US$ Million) Estimates and Forecasts by country, 2021-2034
10.2. Europe
10.2.1. Europe Flow Cytometry in Oncology and Immunology Market revenue (US$ Million) by Offering, 2021-2034
10.2.2. Europe Flow Cytometry in Oncology and Immunology Market revenue (US$ Million) by Technology, 2021-2034
10.2.3. Europe Flow Cytometry in Oncology and Immunology Market revenue (US$ Million) by Type, 2021-2034
10.2.4. Europe Flow Cytometry in Oncology and Immunology Market revenue (US$ Million) by Application, 2021-2034
10.2.5. Europe Flow Cytometry in Oncology and Immunology Market revenue (US$ Million) by End User, 2021-2034
10.2.8. Europe Flow Cytometry in Oncology and Immunology Market revenue (US$ Million) by country, 2021-2034
10.3. Asia Pacific
10.3.1. Asia Pacific Flow Cytometry in Oncology and Immunology Market revenue (US$ Million) by Offering,2021-2034
10.3.2. Asia Pacific Flow Cytometry in Oncology and Immunology Market revenue (US$ Million) by Technology, 2021-2034
10.3.3. Asia-Pacific Flow Cytometry in Oncology and Immunology Market revenue (US$ Million) by Type, 2021-2034
10.3.4. Asia Pacific Flow Cytometry in Oncology and Immunology Market revenue (US$ Million) by Application, 2021-2034
10.3.5. Asia Pacific Flow Cytometry in Oncology and Immunology Market revenue (US$ Million) by End User, 2021-2034
10.3.8. Asia Pacific Flow Cytometry in Oncology and Immunology Market revenue (US$ Million) by country, 2021-2034
10.4. Latin America
10.4.1. Latin America Flow Cytometry in Oncology and Immunology Market revenue (US$ Million) by Offering, 2021-2034
10.4.2. Latin America Flow Cytometry in Oncology and Immunology Market revenue (US$ Million) by Technology, 2021-2034
10.4.3. Latin America Flow Cytometry in Oncology and Immunology Market revenue (US$ Million) by Type,2021-2034
10.4.4. Latin America Flow Cytometry in Oncology and Immunology Market revenue (US$ Million) by Application,2021-2034
10.4.5. Latin America Flow Cytometry in Oncology and Immunology Market revenue (US$ Million) by End User,2021-2034
10.4.6. Latin America Flow Cytometry in Oncology and Immunology Market revenue (US$ Million) by country, 2021-2034
10.5. Middle East & Africa
10.5.1. Middle East & Africa Flow Cytometry in Oncology and Immunology Market revenue (US$ Million) by Offering,2021-2034
10.5.2. Middle East & Africa Flow Cytometry in Oncology and Immunology Market revenue (US$ Million) by Technology, 2021-2034
10.5.3. Middle East & Africa Flow Cytometry in Oncology and Immunology Market revenue (US$ Million) by Type, 2021-2034
10.5.4. Middle East & Africa Flow Cytometry in Oncology and Immunology Market revenue (US$ Million) by Application, 2021-2034
10.5.5. Middle East & Africa Flow Cytometry in Oncology and Immunology Market revenue (US$ Million) by End User, 2021-2034
10.5.6. Middle East & Africa Flow Cytometry in Oncology and Immunology Market revenue (US$ Million) by country, 2021-2034
Chapter 11. Competitive Landscape
11.1. Major Mergers and Acquisitions/Strategic Alliances
11.2. Company Profiles
11.2.1. Agilent Technologies, Inc.
11.2.2. Becton, Dickinson, and Company
11.2.3. Bio-Rad Laboratories, Inc.
11.2.4. Cell Signaling Technology, Inc.
11.2.5. Cytec Biosciences, Inc.
11.2.6. Danaher Corporation
11.2.7. Diasporic S.p.A (Luminex Corporation)
11.2.8. Enzi Beachem Inc.
11.2.9. Laboratory Corporation of America Holdings
11.2.10. Merck Kagan
11.2.11. Millenia Biotic
11.2.12. Neo Genomics Laboratories, Inc.
11.2.13. OPKO Health, Inc.
11.2.14. Sony Group Corporation
11.2.15. Thermos Fisher Scientific Inc.
11.2.16. Other Prominent Players
量子訊息有限公司為 InsightAce Analytic 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們